coadministered cagrilintide and semaglutide in adults with overweight or obesity Summary of REDEFINE 1 REDEFINE 2 trials CagriSema, presented this week at #ADA2025 and published NEJM: REDEFINE 1: β’ π₯ 3,417 participants with (without diabetes) treated PDF] Once-weekly cagrilintide for weight
Pay in 4 interest-free payments of $6.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 19 - Aug 24
![coadministered cagrilintide and semaglutide in adults with overweight or obesity Summary of REDEFINE 1 REDEFINE 2 trials CagriSema, presented this week at #ADA2025 and published NEJM: REDEFINE 1: 3,417 participants with (without diabetes) treated PDF] Once-weekly cagrilintide for weight](https://figures.semanticscholar.org/a9800c8f0dc40d6d18a09ab6d2f14e71a42af380/9-Figure3-1.png)
![coadministered cagrilintide and semaglutide in adults with overweight or obesity Summary of REDEFINE 1 REDEFINE 2 trials CagriSema, presented this week at #ADA2025 and published NEJM: REDEFINE 1: 3,417 participants with (without diabetes) treated PDF] Once-weekly cagrilintide for weight](https://www.2minutemedicine.com/wp-content/uploads/2025/07/2MM_06.22.25_Astrid_1_T2D.jpg)
![coadministered cagrilintide and semaglutide in adults with overweight or obesity Summary of REDEFINE 1 REDEFINE 2 trials CagriSema, presented this week at #ADA2025 and published NEJM: REDEFINE 1: 3,417 participants with (without diabetes) treated PDF] Once-weekly cagrilintide for weight](https://www.nejm.org/cms/asset/0e4b3922-625d-4a45-9015-1d254fd0598b/nejmoa2502082_f1.jpg)






















